Patent applications published 21 July 2010
Selected patent applications from the weekly European Patents Bulletin
- Process for the manufacture of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulphate, pharmaceutical compsn comprising granules obtained by such process and intermediate products thereof
Ferring International 2207526*
- Methods for administering corticosteroid formulations
MAP_Pharmaceuticals 2207527*
- Pharmaceutical compsn
STI_Pharmaceutical 2207528*
- Drug cores for sustained release of therapeutic agents
QLT_Plug Delivery 2207529*
- Sustained delivery of compstatin analogues from gels
Potentia Pharmaceuticals 2207530*
- Self-emulsifying pharmaceutical compsns of rhein or diacerin
Wockhardt Research Centre 2207531*
- Pharmaceutical compsns of rhein or diacerin
Wockhardt Research Centre 2207532*
- Directionally compressible high functionality granular microcrystalline cellulose-based excipient, manufacturing process and use thereof
Mallinckrodt Baker 2207533*
- Mechanical protective layer for solid dosage forms
Laboratoires del Dr Esteve 2207534*
- Poly (urea-urethane) compsns useful as topical medicaments and methods of using the same
Chesson Laboratory Associates 2207535*
- Transdermal drug delivery using an osmolyte and vasoactive agent
BioChemics 2207536*
- Systemic pro-haemostatic effect of sympatheticomimetics with agonistic effects on -adrenergic and/or -adrenergic receptors of the sympathetic nervous system, related to improved clot strength
Hemostasis Holding 2207537*
- Compsns comprising cetirizine and a non beta-2-adrenoreceptor agonist, a beta-2-adrenoreceptor agonist or an anti-inflammatory and the use thereof for the treatment of respiratory disorders
E-Therapeutics 2207538*
- Skin and surface disinfectant compsns containing botanicals
The Trustees of Columbia University 2207539*
- Cyclopropyl aryl amide derivatives and uses thereof
F_Hoffmann-La Roche 2207540*
- Use of sulphonyl-substituted 2-sulphonaminobenzoic acid N-phenylamides in the treatment of pain
Sanofi-Aventis Deutschland 2207541*
- A method of hormone suppression in humans
NV_Organon 2207542*
- Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for treating autoimmune diseases or inhibiting immune function
Resolvyx Pharmaceuticals 2207543*
- Treatment of oestrogen dependant conditions in pre-menopausal women
PregLem 2207544*
- Methods for treating post-operative effects such as spasticity and shivering with clonidine
Medtronic 2207545*
- 5-lipoxygenase-activating protein (FLAP)_inhibitors
Amira Pharmaceuticals 2207547*
- Breast cancer therapy
Cohen-Armon, Malka 2207548*
- Modulators of muscarinic receptors
Vertex Pharmaceuticals 2207549*
- Tetrahydroquinone derivatives for treating post-traumatic stress disorders
Actelion Pharmaceuticals 2207550*
- Use of 3, 11B-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis
Biovail Laboratories International 2207551*
- Use of a combination of an opioid agonist and an opioid antagonist for the treatment of Crohn’s disease and the symptoms associated with Crohn’s disease
Euro-Celtique 2207552*
- Potent combinations of zidovudine and drugs that select for the k65R mutation in the HIV polymerase
Emory University 2207553*
- C4’-substituted-2-deoxyadenosine analogues and methods of treating HIV
The USA as represented by the Secretary, Department of Health and Human Services 2207554*
- Novel compounds for the treatment or alleviation of oedema, and methods for their use
InDex Pharmaceuticals 2207555*
- Compsns based on positively charged cyclodextrins for preserving cells, tissues and organs, method of obtaining the same and uses thereof
Biocydex 2207556*
- Use of metal astringents for the treatment and prevention of hairy heel warts
Ecolab 2207557*
- Tissue-engineered endothelial and epithelial implants differentially and synergistically regulate tissue repair
Massachusetts Institute of Technology 2207558*
- Wound-healing agent containing momordicae semen extract
SK_Chemicals 2207559*
- Use of fibronectin fragment (196-203) as a therapeutic agent
Mondobiotech Laboratories 2207560*
- Improved antitumoral treatments
Pharma Mar; Albert Einstein College of Medicine of Yeshiva University 2207561*
- Activin-actriia antagonists and uses for decreasing or inhibiting FSH_secretion
Acceleron Pharma 2207562*
- Preventative and therapeutic vaccine for stroke and neurological disorders
Reddy, Jeeri 2207563*
- Use of MVA_to treat prostate cancer
BN_ImmunoTherapeutics 2207564*
- Immunotherapy regimes dependent of APOE_status
Janssen Alzheimer Immunotherapy 2207565*
- Methods for designing and preparing vaccines comprising directed sequence polymer compsns via the directed expansion of epitopes
Peptimmune 2207566*
- Immunogenic formulation
Pontificia Universidad Catolica de Chile 2207567*
- Antibodies specific for the proto-fibril form of beta-amyloid protein
The Rockefeller University 2207568*
- Pharmaceutical compsns containing benfotiamine and one or one more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin
Merck Patent 2207569*
- Drug carriers
Nitto Denko 2207570*